.png){kind=logo}
Vehicle often ethanol used in combination to increase the solubility of drugs.
Pharmaceutics Pharmacist Competitive Exams
Q. Vehicle often ethanol used in combination to increase the solubility of drugs.
Ans → cosolvent
Explanation →
This question is taken from the test/quiz post: one liners Pharmaceutics| B.Pharmacy| Pharmacy file-2 - attemp/practice
More oneliners in - one liners Pharmaceutics| B.Pharmacy| Pharmacy file-2
Q. Small edible package made usually from gelatin or other materials that can be filled with drugs (solids or liquids) to produce a unit dose, mainly for oral use.
Ans → capsule
Explanation →
Q. Transfer of a drug across a membrane by a transporter (often a protein) constituent of the cytosol membrane.
Ans → carrier-mediated drug transport
Explanation →
Q. Reversal of coagulation or flocculation, i.e., the dispersion of aggregates to form a stable colloidal suspension or emulsion.
Ans → deflocculation
Explanation →
Q. A Pharmaceutical preparation that releases the drug(s) at a time other than promptly after administration.
Ans →
Explanation →
Q. Close, tight aggregation of colloid particles, emulsion droplets, suspension particles, which are difficult to redisperse.
Ans → coagulation
Explanation →
Q. Process that occurs when the vapor pressure of the saturated aqueous solution of a substance is less than the vapor pressure of water in the ambient air.
Ans → deliquescence
Explanation →
Q. Technological process consisting of the application of a substance, which forms a layer e.g, to protect the drug
Ans → coating
Explanation →
Q. A Substance that absorbs sufficient moisture from the atmosphere to dissolve itself.
Ans → deliquescent
Explanation →
Q. A solid dosage form prepared to a desired shape, usually in large-scale production, by means of high pressure in a punch and die.
Ans → compressed tablet
Explanation →
Q. The deposit of a drug in a body created by injection or by a similar mode of introduction to form a source of slow release.
Ans → depot
Explanation →
Q. Vehicle often ethanol used in combination to increase the solubility of drugs.
Ans → cosolvent
Explanation →
Q. Surfactant (or a mixture containing one or more surfactants) having cleaning properties in dilute solutions
Ans → detergent
Explanation →
Q. Name a property, which serves as basis for the process whereby surfactants are used for the removal of foreign matter from surfaces (including dirt from clothes or body surfaces).
Ans → detergency
Explanation →
Q. The Threshold detergent concentration at which micelle formation begins in the bulk phase is called
Ans → critical micelle concentration (cmc)
Explanation →
More one-liners in - Pharmaceutics
Q. Small edible package made usually from gelatin or other materials that can be filled with drugs (solids or liquids) to produce a unit dose, mainly for oral use.
Ans → capsule
Explanation →
Q. A solid dosage form prepared to a desired shape, usually in large-scale production, by means of high pressure in a punch and die.
Ans → compressed tablet
Explanation →
Q. Use of products containing genetic material (e.g., pDNA, antisense DNA, si RNA) to treat a disease or condition, or to modify or manipulate the expression of genetic material or to alter the biological properties of living cells.
Ans → gene therapy
Explanation →
Q. Enzymes lose the catalytic activity at temperature above 70C due to
Ans → Denaturation
Explanation →
Q. Technological process consisting of the application of a substance, which forms a layer e.g, to protect the drug
Ans → coating
Explanation →
Q. The prefix sn used to represent glycerol, sn stands for
Ans → Stereospecific number
Explanation →
Q. The third stage of acute disease, during which the number of pathogens present in the host is greatest and the signs and symptoms of disease are most severe
Ans → period of illness
Explanation →
Q. A formal non-ambiguous, nomenclature system for the assignment of absolute configuration of structure to chiral atoms, using the Cahn, Ingold and Prelog priority rules.
Ans → R,S convention
Explanation →
Q. Type of comparative bioavailability study designed in such a way as to take into account differences in bioavailability arising from differences between patients suffering from disease
Ans → crossover study
Explanation →
Q. The determination of the potency of a physical, chemical or biological agent, by means of a biological indicator
Ans → Biological Assay
Explanation →
Q. The sideways projection of a carbon-carbon single bond and the attached substituents.
Ans → sawhorse projection
Explanation →
Q. Which enzymes in glycolysis catalyses an irreversible reaction
Ans → Pyruvate kinase , Phosphofructokinase, Hexokinase
Explanation →
Q. Vaccine composed of whole pathogen cells or viruses that have been killed or inactivated through treatment with heat, radiation, or chemicals
Ans → inactivated vaccine
Explanation →
Q. A process in which the forward reaction can reach an equilibrium with the reverse reaction.
Ans → reversible process
Explanation →
Q. Initial, typically larger than the maintenance dose of a drug given to a patient at the start of pharmacotherapy.
Ans → loading dose
Explanation →
Q. The term given to organic molecules which contain no multiple bonds.
Ans → saturated
Explanation →
Q. Measure of the fraction of a given drug that is absorbed intact into the systemic circulation from a dosage form, relative to a recognized, clinically proven, standard dosage form of that drug.
Ans → relative bioavailability
Explanation →
Q. Dry solid material consisting of many, usually free flowing, fine particles.
Ans → powder
Explanation →
Q. Name a method of acid-fast staining that does not use heat to infuse the primary stain, carbolfuchsin, into acid-fast cells
Ans → Kinyoun technique
Explanation →
Q. Name the inflammation of the mouth and gums that is often caused by the HSV-1 virus
Ans → herpetic gingivostomatitis
Explanation →
Q. Specific case of drug embedding in insoluble excipients (typically in a polymer) in order to achieve extended release.
Ans → matrix formulation
Explanation →
Q. The percentage of yield that occurred versus the theoretical yield.
Ans → percent yield
Explanation →
Q. Relationship between two preparations of the same drug in the same dosage form that have a similar bioavailability.
Ans → bioequivalence
Explanation →
Q. The bonds responsible for a majority of high-energy compounds are
Ans → Phosphoanhydride bonds
Explanation →
Q. A very strong attraction between two or more atoms that are sharing their electrons.
Ans → Covalent Bond
Explanation →
Q. Process of enclosing a drug in a (micro or nano) particle (capsule, liposome, polymer).
Ans → encapsulation
Explanation →
Q. The inorganic element found in the structure of majority of high-energy compounds
Ans → Phosphorus
Explanation →
Q. The process of separating the lighter particles of a powder from the heavier ones by means of an up- ward-directed stream of fluid (gas or liquid).
Ans → elutriation
Explanation →
Q. The Schick test is done to detect the immunity or susceptibility to _______.
Ans → Diphtheria
Explanation →